Boston Common Asset Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.9M Sell
142,958
-2,681
-2% -$309K 1% 24
2026
Q1
$17.4M Buy
145,639
+10,119
+7% +$1.33M 1.12% 23
2025
Q4
$18.5M Buy
135,520
+10,853
+9% +$1.56M 1.11% 21
2025
Q3
$18.4M Sell
124,667
-362
-0.3% -$50.2K 0.51% 63
2025
Q2
$16.2M Sell
125,029
-2,328
-2% -$282K 0.45% 81
2025
Q1
$15.2M Buy
127,357
+8,053
+7% +$998K 0.46% 81
2024
Q4
$13.8M Sell
119,304
-38,405
-24% -$4.86M 0.4% 95
2024
Q3
$21.3M Sell
157,709
-15,233
-9% -$2.04M 0.56% 66
2024
Q2
$23.5M Sell
172,942
-11,438
-6% -$1.56M 0.6% 56
2024
Q1
$23.8M Sell
184,380
-31,306
-15% -$3.78M 0.57% 60
2023
Q4
$24.7M Sell
215,686
-17,014
-7% -$1.7M 0.56% 63
2023
Q3
$21.2M Sell
232,700
-5,099
-2% -$526K 0.51% 74
2023
Q2
$26.8M Sell
237,799
-4,104
-2% -$434K 0.57% 69
2023
Q1
$25.3M Sell
241,903
-6,168
-2% -$644K 0.53% 70
2022
Q4
$27.4M Sell
248,071
-34,167
-12% -$3.58M 1.31% 16
2022
Q3
$24.7M Sell
282,238
-1,907
-0.7% -$173K 1.29% 19
2022
Q2
$22.2M Buy
284,145
+10,196
+4% +$842K 1.11% 27
2022
Q1
$23.4M Buy
273,949
+75,485
+38% +$7.23M 1.01% 27
2021
Q4
$23.8M Buy
198,464
+1,110
+0.6% +$138K 0.96% 36
2021
Q3
$24.4M Sell
197,354
-83,138
-30% -$10.7M 1.06% 32
2021
Q2
$33.6M Buy
280,492
+217,225
+343% +$24.8M 1.45% 17
2021
Q1
$6.65M Sell
63,267
-680
-1% -$68.9K 0.42% 73
2020
Q4
$6.51M Buy
63,947
+24,556
+62% +$2.31M 0.45% 71
2020
Q3
$3.31M Buy
39,391
+6,355
+19% +$495K 0.32% 88
2020
Q2
$2.15M Buy
33,036
+12,336
+60% +$814K 0.23% 98
2020
Q1
$1.35M Buy
20,700
+2,510
+14% +$198K 0.19% 104
2019
Q4
$1.43M Sell
18,190
-7,290
-29% -$567K 0.17% 110
2019
Q3
$2.03M Sell
25,480
-995
-4% -$78.2K 0.25% 88
2019
Q2
$2.21M Sell
26,475
-911
-3% -$72.6K 0.28% 87
2019
Q1
$2.17M Sell
27,386
-1,265
-4% -$92.3K 0.28% 87
2018
Q4
$1.91M Sell
28,651
-30
-0.1% -$2.08K 0.28% 90
2018
Q3
$2.29M Buy
28,681
+2,705
+10% +$202K 0.28% 83
2018
Q2
$1.75M Buy
25,976
+6,045
+30% +$439K 0.22% 90
2018
Q1
$1.53M Sell
19,931
-5,383
-21% -$398K 0.18% 99
2017
Q4
$1.73M Buy
25,314
+2,882
+13% +$191K 0.2% 94
2017
Q3
$1.41M Sell
22,432
-60
-0.3% -$3.59K 0.18% 98
2017
Q2
$1.25M Sell
22,492
-130
-0.6% -$6.77K 0.16% 106
2017
Q1
$1.14M Sell
22,622
-780
-3% -$38K 0.15% 108
2016
Q4
$1.16M Buy
23,402
+325
+1% +$16.5K 0.17% 103
2016
Q3
$1.21M Buy
23,077
+6,012
+35% +$295K 0.07% 175
2016
Q2
$762K Sell
17,065
-1,745
-9% -$75.8K 0.04% 205
2016
Q1
$769K Buy
18,810
+80
+0.4% +$2.95K 0.04% 209
2015
Q4
$684K Hold
18,730
0.04% 221
2015
Q3
$615K Buy
18,730
+8,260
+79% +$278K 0.04% 226
2015
Q2
$388K Sell
10,470
-230
-2% -$8.37K 0.02% 247
2015
Q1
$375K Sell
10,700
-350
-3% -$12.3K 0.02% 250
2014
Q4
$421K Buy
11,050
+5,095
+86% +$186K 0.02% 241
2014
Q3
$211K Sell
5,955
-280
-4% -$10.4K 0.01% 261
2014
Q2
$244K Sell
6,235
-700
-10% -$26.2K 0.01% 257
2014
Q1
$253K Sell
6,935
-475
-6% -$17.3K 0.01% 290
2013
Q4
$256K Buy
7,410
+570
+8% +$18.3K 0.01% 275
2013
Q3
$191K Sell
6,840
-5,670
-45% -$151K 0.01% 295
2013
Q2
$337K Buy
+12,510
New +$345K 0.02% 266

Other funds holding XYL

Boston Common Asset Management's XYL Position: Q2 2026 in Review

Boston Common Asset Management reduced its Xylem (XYL) stake by 1.8% in Q2 2026, selling an estimated $309K and leaving 142,958 shares worth $16.9M. The position accounts for 1% of the portfolio, ranked #24.

Boston Common Asset Management first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.6M in Q2 2021. 274 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Boston Common Asset Management held 142,958 shares of Xylem worth $16.9M as of Q2 2026.
  • Boston Common Asset Management sold 2,681 Xylem shares in Q2 2026, an estimated $309K.
  • Xylem made up 1% of Boston Common Asset Management's portfolio in Q2 2026, its #24 holding.
  • Boston Common Asset Management first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • Boston Common Asset Management's Xylem position peaked at $33.6M in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Boston Common Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.